PROCEPT BioRobotics (PRCT) Earnings Analysis

PROCEPT BioRobotics (PRCT) has no confirmed upcoming earnings date. Last quarter (2026-04-29) it missed with EPS -0.56 USD vs -0.55 USD est (-1.8%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E -9.73.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PRCT next report earnings?

No confirmed upcoming earnings date is currently scheduled for PRCT. This page updates as the calendar is published.

PRCT earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-29-0.56 USD-0.55 USD-1.8%Miss
2026-02-25-0.53 USD-0.32 USD-65.6%Miss
2025-04-24-0.45 USD-0.49 USD+8.2%Beat
2024-10-28-0.4 USD-0.48 USD+16.7%Beat
2024-08-01-0.5 USD-0.52 USD+3.8%Beat

Beat rate: 3/5 (60%) over reported quarters with consensus data.

PRCT valuation and analyst view

Trailing P/E-9.73
Trailing EPS-1.81331 USD
Price / book2.88
Dividend yield0.00%
Market cap1.01B
Analyst consensusBuy (9 buy / 5 hold / 1 sell)
Avg price target29.75 USD

Related research pages

Frequently asked questions

When is PROCEPT BioRobotics (PRCT)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for PRCT. This page updates as the calendar is published.

Did PRCT beat earnings last quarter?

In its 2026-04-29 report, PRCT posted EPS of -0.56 USD versus a -0.55 USD estimate — a miss of 1.8%.

What is PRCT's earnings track record?

Over the last 5 reported quarters with consensus data, PRCT beat estimates 3 times (60%).

What is PRCT's current P/E ratio and EPS?

PRCT trades at a trailing P/E of -9.73 on trailing EPS of -1.8133106828759002 USD.

What do analysts rate PRCT?

Analyst consensus is "Buy" across 15 ratings (0 strong buy, 9 buy, 5 hold, 1 sell, 0 strong sell). Average 12-month price target: 29.75 USD.